United States Biotechnology & Medical Research

Filana Therapeutics, Inc. (FLNA)

Track

Track

Filana Therapeutics, Inc. experienced three insider trading transactions over the past ninety days, all involving CEO Barry Richard. These acquisitions totaled $356,328.14 in value. Despite a 29.1% decline in stock price during this period, no selling activity occurred. The latest results financiers were reported on August 13, 2026.
Ticker: FLNA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Filana Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
86.41
Quantity 81,156 -29.6%
Value US$1,074,587
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
171.02
Quantity 12,187 -25.4%
Value US$4,731,546
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
329.60
Quantity 27,326 +23.3%
Value US$1,374,110
0.6
Anderson Robert Eugene Jr Non-Executive Director
Transaction date
Purchase
Price
2.90
Quantity 8,600 +inf%
Value US$24,940
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.76
Quantity 150,000 +19.0%
Value US$414,000
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.75
Quantity 73,385 +10.3%
Value US$201,809
1.5
Cook Robert Christopher Chief Operating & Legal Office Officer
Transaction date
Purchase
Price
2.91
Quantity 13,725 +inf%
Value US$39,940
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.28
Quantity 7,172 +1.0%
Value US$16,352
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.29
Quantity 46,908 +7.1%
Value US$107,419
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.25
Quantity 400 +0.1%
Value US$900
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.24
Quantity 185,233 +39.0%
Value US$414,922
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.13
Quantity 5,400 +1.2%
Value US$11,502
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Sale
Price
3.86
Quantity 59,800 -83.9%
Value US$230,828
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Sale
Price
3.82
Quantity 2,000 -100.0%
Value US$7,640
2.3
Kupiec James William Chief Medical Officer Officer
Transaction date
Sale
Price
3.87
Quantity 4,000 -100.0%
Value US$15,480
3.0
Schoen, Eric J. (SAVA) Officer Officer
Transaction date
Proposed sale
Price
3.82
Quantity 2,000
Value US$7,640
3.0
Schoen Eric Officer Officer
Transaction date
Proposed sale
Price
3.86
Quantity 59,800
Value US$230,966
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
17.45
Quantity 30,000 +3.5%
Value US$523,500
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
16.65
Quantity 16,571 +6.0%
Value US$275,907
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
16.80
Quantity 1,906 +0.7%
Value US$32,021
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
25.76
Quantity 77,276 +39.1%
Value US$1,990,630
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
26.13
Quantity 11,565 +6.2%
Value US$302,193
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
23.79
Quantity 36,159 +24.1%
Value US$860,223
2.3
Kupiec James William Chief Clinical Dev. Officer Officer
Transaction date
Purchase
Price
24.44
Quantity 2,500 +inf%
Value US$61,100
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
20.69
Quantity 100,000 +10.8%
Value US$2,069,000
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
19.95
Quantity 2,500 +14.5%
Value US$49,875
1.6
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
9.59
Quantity 10,000 +0.9%
Value US$95,900
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
8.92
Quantity 36,281 +4.1%
Value US$323,627
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
7.04
Quantity 2,000 +7.9%
Value US$14,080
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
6.98
Quantity 213,719 +32.3%
Value US$1,491,759
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
7.03
Quantity 10,000 +65.4%
Value US$70,300
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
5.53
Quantity 100,000 +10.3%
Value US$553,000
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
4.15
Quantity 10,000 +1.0%
Value US$41,500
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
2.20
Quantity 423,788 +177.4%
Value US$932,334
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.86
Quantity 76,212 +46.9%
Value US$141,754
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
1.88
Quantity 5,300 +53.0%
Value US$9,964
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
1.65
Quantity 2,599 +inf%
Value US$4,288
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
1.06
Quantity 10,000 +inf%
Value US$10,600
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
1.31
Quantity 512,660 -23.7%
Value US$671,738
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 37,817 +30.3%
Value US$39,708
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 30,992 +33.0%
Value US$32,542
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 21,420 +29.6%
Value US$21,420
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
0.96
Quantity 9,771 +15.6%
Value US$9,380
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.91
Quantity 8,000 -0.4%
Value US$7,254
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.95
Quantity 48,000 -2.2%
Value US$45,682
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
1.02
Quantity 1,200,000 -35.1%
Value US$1,222,200
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
3.76
Quantity 31,838 +9.4%
Value US$119,711
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
3.69
Quantity 18,162 +5.7%
Value US$67,018
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.44
Quantity 25,000 -8.8%
Value US$111,008
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.75
Quantity 50,000 -1.2%
Value US$237,500
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.50
Quantity 265,000 -5.8%
Value US$1,193,162
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.59
Quantity 7,000 -2.4%
Value US$32,118
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.83
Quantity 67,000 -1.4%
Value US$323,409
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.89
Quantity 8,000 -2.7%
Value US$39,122
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.91
Quantity 10,000 -3.2%
Value US$49,060
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.89
Quantity 25,000 -7.5%
Value US$122,125
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.20
Quantity 44,417 -0.9%
Value US$186,600
BARBIER REMI CEO, Chairman of the Board Executive Director Large shareholder
Transaction date
Purchase
Price
4.22
Quantity 5,000 +0.1%
Value US$21,095
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
6.13
Quantity 15,000 -0.3%
Value US$91,950
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.60
Quantity 16,264 -0.3%
Value US$91,078
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.87
Quantity 11,097 -0.2%
Value US$65,139
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.81
Quantity 6,468 -0.1%
Value US$37,586
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.53
Quantity 9,496 -0.2%
Value US$52,541
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.64
Quantity 6,582 -0.1%
Value US$37,129
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.75
Quantity 6,457 -0.1%
Value US$37,108
SCHOENHARD GRANT Chief Scientific Officer Officer
Transaction date
Planned sale
Price
5.54
Quantity 1,500 -3.0%
Value US$8,310
BARBIER REMI CEO and Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.37
Quantity 7,071 -0.1%
Value US$37,964
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-01 2026-09-30 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
81,156 -29.6%
86.41
US$1,074,587 		81,156 -29.6% 86.41 US$1,074,587
2026-10-01 2026-09-29 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
12,187 -25.4%
171.02
US$4,731,546 		12,187 -25.4% 171.02 US$4,731,546
2026-09-30 2026-09-28 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
27,326 +23.3%
329.60
US$1,374,110 		27,326 +23.3% 329.60 US$1,374,110
2025-11-25 2025-11-24 B Purchase
0.6
Anderson Robert Eugene Jr
Non-Executive Director
8,600 +inf%
2.90
US$24,940 		8,600 +inf% 2.90 US$24,940
2025-11-24 2025-11-20 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
150,000 +19.0%
2.76
US$414,000 		150,000 +19.0% 2.76 US$414,000
2025-11-20 2025-11-19 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
73,385 +10.3%
2.75
US$201,809 		73,385 +10.3% 2.75 US$201,809
2025-10-02 2025-09-30 B Purchase
1.5
Cook Robert Christopher

Chief Operating & Legal Office

Officer
13,725 +inf%
2.91
US$39,940 		13,725 +inf% 2.91 US$39,940
2025-09-23 2025-09-22 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
7,172 +1.0%
2.28
US$16,352 		7,172 +1.0% 2.28 US$16,352
2025-09-22 2025-09-19 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
46,908 +7.1%
2.29
US$107,419 		46,908 +7.1% 2.29 US$107,419
2025-09-22 2025-09-19 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
400 +0.1%
2.25
US$900 		400 +0.1% 2.25 US$900
2025-09-22 2025-09-18 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
185,233 +39.0%
2.24
US$414,922 		185,233 +39.0% 2.24 US$414,922
2025-09-22 2025-09-18 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
5,400 +1.2%
2.13
US$11,502 		5,400 +1.2% 2.13 US$11,502
2024-12-03 2024-11-29 S Sale
3.0
Schoen Eric

Chief Financial Officer

Officer
59,800 -83.9%
3.86
US$230,828 		59,800 -83.9% 3.86 US$230,828
2024-12-03 2024-11-29 S Sale
3.0
Schoen Eric

Chief Financial Officer

Officer
2,000 -100.0%
3.82
US$7,640 		2,000 -100.0% 3.82 US$7,640
2024-12-03 2024-11-29 S Sale
2.3
Kupiec James William

Chief Medical Officer

Officer
4,000 -100.0%
3.87
US$15,480 		4,000 -100.0% 3.87 US$15,480
2024-12-02 2024-11-29 PrS Proposed sale
3.0
Schoen, Eric J. (SAVA)

Officer

Officer
2,000
3.82
US$7,640 		2,000 3.82 US$7,640
2024-11-29 2024-11-29 PrS Proposed sale
3.0
Schoen Eric

Officer

Officer
59,800
3.86
US$230,966 		59,800 3.86 US$230,966
2023-08-24 2023-08-23 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
30,000 +3.5%
17.45
US$523,500 		30,000 +3.5% 17.45 US$523,500
2023-08-23 2023-08-22 B Purchase
3.2
Barry Richard
Non-Executive Director
16,571 +6.0%
16.65
US$275,907 		16,571 +6.0% 16.65 US$275,907
2023-08-23 2023-08-21 B Purchase
3.2
Barry Richard
Non-Executive Director
1,906 +0.7%
16.80
US$32,021 		1,906 +0.7% 16.80 US$32,021
2023-03-08 2023-03-07 B Purchase
3.2
Barry Richard
Non-Executive Director
77,276 +39.1%
25.76
US$1,990,630 		77,276 +39.1% 25.76 US$1,990,630
2023-03-08 2023-03-06 B Purchase
3.2
Barry Richard
Non-Executive Director
11,565 +6.2%
26.13
US$302,193 		11,565 +6.2% 26.13 US$302,193
2022-08-25 2022-08-23 B Purchase
3.2
Barry Richard
Non-Executive Director
36,159 +24.1%
23.79
US$860,223 		36,159 +24.1% 23.79 US$860,223
2022-08-24 2022-08-23 B Purchase
2.3
Kupiec James William

Chief Clinical Dev. Officer

Officer
2,500 +inf%
24.44
US$61,100 		2,500 +inf% 24.44 US$61,100
2022-08-16 2022-08-12 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
100,000 +10.8%
20.69
US$2,069,000 		100,000 +10.8% 20.69 US$2,069,000
2022-08-16 2022-08-12 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
2,500 +14.5%
19.95
US$49,875 		2,500 +14.5% 19.95 US$49,875
2020-09-24 2020-09-24 B Purchase
1.6
BARBIER REMI

President and CEO

Executive Director
10,000 +0.9%
9.59
US$95,900 		10,000 +0.9% 9.59 US$95,900
2020-09-21 2020-09-18 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
36,281 +4.1%
8.92
US$323,627 		36,281 +4.1% 8.92 US$323,627
2020-09-17 2020-09-17 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
2,000 +7.9%
7.04
US$14,080 		2,000 +7.9% 7.04 US$14,080
2020-09-17 2020-09-17 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
213,719 +32.3%
6.98
US$1,491,759 		213,719 +32.3% 6.98 US$1,491,759
2020-09-17 2020-09-17 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
10,000 +65.4%
7.03
US$70,300 		10,000 +65.4% 7.03 US$70,300
2019-12-31 2019-12-31 B Purchase BARBIER REMI

President and CEO

Executive Director
100,000 +10.3%
5.53
US$553,000 		100,000 +10.3% 5.53 US$553,000
2019-12-26 2019-12-26 B Purchase BARBIER REMI

President and CEO

Executive Director
10,000 +1.0%
4.15
US$41,500 		10,000 +1.0% 4.15 US$41,500
2019-12-20 2019-12-20 B Purchase ROBERTSON SANFORD Non-Executive Director
423,788 +177.4%
2.20
US$932,334 		423,788 +177.4% 2.20 US$932,334
2019-12-19 2019-12-19 B Purchase ROBERTSON SANFORD Non-Executive Director
76,212 +46.9%
1.86
US$141,754 		76,212 +46.9% 1.86 US$141,754
2019-12-19 2019-12-19 B Purchase Schoen Eric

Chief Financial Officer

Officer
5,300 +53.0%
1.88
US$9,964 		5,300 +53.0% 1.88 US$9,964
2019-12-20 2019-12-18 B Purchase BARBIER REMI

President and CEO

Executive Director
2,599 +inf%
1.65
US$4,288 		2,599 +inf% 1.65 US$4,288
2019-05-15 2019-05-14 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
10,000 +inf%
1.06
US$10,600 		10,000 +inf% 1.06 US$10,600
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
512,660 -23.7%
1.31
US$671,738 		512,660 -23.7% 1.31 US$671,738
2018-09-27 2018-09-27 B Purchase ROBERTSON SANFORD Non-Executive Director
37,817 +30.3%
1.05
US$39,708 		37,817 +30.3% 1.05 US$39,708
2018-09-26 2018-09-26 B Purchase ROBERTSON SANFORD Non-Executive Director
30,992 +33.0%
1.05
US$32,542 		30,992 +33.0% 1.05 US$32,542
2018-09-26 2018-09-25 B Purchase ROBERTSON SANFORD Non-Executive Director
21,420 +29.6%
1.00
US$21,420 		21,420 +29.6% 1.00 US$21,420
2018-09-26 2018-09-24 B Purchase ROBERTSON SANFORD Non-Executive Director
9,771 +15.6%
0.96
US$9,380 		9,771 +15.6% 0.96 US$9,380
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
8,000 -0.4%
0.91
US$7,254 		8,000 -0.4% 0.91 US$7,254
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
48,000 -2.2%
0.95
US$45,682 		48,000 -2.2% 0.95 US$45,682
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
1,200,000 -35.1%
1.02
US$1,222,200 		1,200,000 -35.1% 1.02 US$1,222,200
2013-11-07 2013-11-06 B Purchase ROBERTSON SANFORD Non-Executive Director
31,838 +9.4%
3.76
US$119,711 		31,838 +9.4% 3.76 US$119,711
2013-11-07 2013-11-04 B Purchase ROBERTSON SANFORD Non-Executive Director
18,162 +5.7%
3.69
US$67,018 		18,162 +5.7% 3.69 US$67,018
2011-10-24 2011-10-18 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
25,000 -8.8%
4.44
US$111,008 		25,000 -8.8% 4.44 US$111,008
2011-10-05 2011-10-04 S Sale Sabretooth Master Fund, L.P. Large shareholder
50,000 -1.2%
4.75
US$237,500 		50,000 -1.2% 4.75 US$237,500
2011-10-05 2011-10-04 S Sale Sabretooth Master Fund, L.P. Large shareholder
265,000 -5.8%
4.50
US$1,193,162 		265,000 -5.8% 4.50 US$1,193,162
2011-10-04 2011-10-04 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
7,000 -2.4%
4.59
US$32,118 		7,000 -2.4% 4.59 US$32,118
2011-10-05 2011-10-03 S Sale Sabretooth Master Fund, L.P. Large shareholder
67,000 -1.4%
4.83
US$323,409 		67,000 -1.4% 4.83 US$323,409
2011-10-04 2011-10-03 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
8,000 -2.7%
4.89
US$39,122 		8,000 -2.7% 4.89 US$39,122
2011-10-04 2011-09-30 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
10,000 -3.2%
4.91
US$49,060 		10,000 -3.2% 4.91 US$49,060
2011-09-21 2011-09-15 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
25,000 -7.5%
4.89
US$122,125 		25,000 -7.5% 4.89 US$122,125
2011-08-10 2011-08-08 S Sale Sabretooth Master Fund, L.P. Large shareholder
44,417 -0.9%
4.20
US$186,600 		44,417 -0.9% 4.20 US$186,600
2011-08-08 2011-08-08 B Purchase BARBIER REMI

CEO, Chairman of the Board

Executive Director Large shareholder
5,000 +0.1%
4.22
US$21,095 		5,000 +0.1% 4.22 US$21,095
2010-10-04 2010-10-04 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
15,000 -0.3%
6.13
US$91,950 		15,000 -0.3% 6.13 US$91,950
2010-09-08 2010-09-07 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
16,264 -0.3%
5.60
US$91,078 		16,264 -0.3% 5.60 US$91,078
2010-09-02 2010-09-02 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
11,097 -0.2%
5.87
US$65,139 		11,097 -0.2% 5.87 US$65,139
2010-08-10 2010-08-09 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,468 -0.1%
5.81
US$37,586 		6,468 -0.1% 5.81 US$37,586
2010-08-10 2010-08-06 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
9,496 -0.2%
5.53
US$52,541 		9,496 -0.2% 5.53 US$52,541
2010-08-04 2010-08-04 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,582 -0.1%
5.64
US$37,129 		6,582 -0.1% 5.64 US$37,129
2010-08-04 2010-08-03 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,457 -0.1%
5.75
US$37,108 		6,457 -0.1% 5.75 US$37,108
2010-07-20 2010-07-16 PlS Planned sale SCHOENHARD GRANT

Chief Scientific Officer

Officer
1,500 -3.0%
5.54
US$8,310 		1,500 -3.0% 5.54 US$8,310
2010-07-08 2010-07-07 PlS Planned sale BARBIER REMI

CEO and Chairman of the Board

Executive Director Large shareholder
7,071 -0.1%
5.37
US$37,964 		7,071 -0.1% 5.37 US$37,964
Explore more

More insider trading research around Filana Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America